Rock Solid Technologies is purchasing the meeting management platform developer in a deal allowing Propylon to exit.

BioLife Solutions will issue more than 6.6 million shares to acquire Ohio University-affiliated Stirling Ultracold in an all-stock transaction.

Cambridge Enterprise is celebrating another win with the acquisition of Smap Energy by Enechange.

The gene therapy developer focused on cardiovascular and central nervous system diseases will merge with Chardan Healthcare Acquisition 2 Corp to list on NYSE.

The Petronas and TNSC-backed 3D printing tedchnology provider has agreed to list through a reverse takeover deal at a $1.6bn valuation.

Bayer could exit the drug discovery technology developer should it complete an initial public offering on the Nasdaq Global Select Market.

The Novartis-backed gene therapy developer will merge with Chardan Healthcare Acquisition 2 Corp and take a New York Stock Exchange listing.

API integration platform developer Cloud Elements has been acquired after raising more than $46m from investors including American Express Ventures.

Appriss Health is paying a reported $500m to buy healthcare collaboration platform developer PatientPing, allowing Alphabet's GV to exit.

The Access Industries-backed content engagement software producer will be valued above $11bn once the reverse merger closes.